Latest News & Updates
Breaking News
6 hours ago
Vaibhavi M.
Other trending news you may like to read
Novo Nordisk To Acquire Akero Therapeutics, Expanding Leadership In Metabolic And Liver Disease Treatments
Novo Nordisk will acquire Akero Therapeutics for up to $5.2B, adding its Phase 3 FGF21 analogue efruxifermin (EFX) for MASH to strengthen its metabolic and liver disease portfolio.
Vaibhavi M.
Acurx Pharmaceuticals Secures New Patent in Australia For Novel DNA Polymerase IIIC Inhibitors
Acurx Pharmaceuticals secures an Australian patent for its DNA Polymerase IIIC inhibitors, expanding global protection for its next-gen antibiotics targeting resistant Gram-positive infections.
Vaibhavi M.
Adial Pharmaceuticals Achieves Key Milestone With Analytical Validation Of Genetic Test For AD04 Phase 3 Trials
Adial Pharmaceuticals completes analytical validation of a cheek swab genetic test supporting FDA registration of AD04, a precision therapy for Alcohol Use Disorder in biomarker-defined patients.
Vaibhavi M.
Autonomix Medical Receives U.S. Patent For Precision Cardiac Neuromodulation And Feedback Therapy
Autonomix Medical secures U.S. patent for precision nerve-targeted cardiac therapies, enabling closed-loop treatment of heart tissues for arrhythmia, heart failure, and hypertension.
Vaibhavi M.
